Handa Pharmaceuticals, Inc. (TPEX:6620)
Taiwan · Delayed Price · Currency is TWD 82.30
+0.20 (0.24%)
Sep 4, 2025, 2:57 PM CST
Handa Pharmaceuticals Revenue
Handa Pharmaceuticals had revenue of 469.90M TWD in the quarter ending June 30, 2025, with 118.02% growth. This brings the company's revenue in the last twelve months to 1.34B, up 37.47% year-over-year. In the year 2024, Handa Pharmaceuticals had annual revenue of 830.67M, down -24.92%.
Revenue (ttm)
1.34B
Revenue Growth
+37.47%
P/S Ratio
9.72
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 830.67M | -275.65M | -24.92% |
| Dec 31, 2023 | 1.11B | 908.64M | 459.66% |
| Dec 31, 2022 | 197.68M | 168.44M | 576.16% |
| Dec 31, 2021 | 29.24M | 376.00K | 1.30% |
| Dec 31, 2020 | 28.86M | -55.21M | -65.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 44.83M |
| PharmaEssentia | 12.63B |
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| Lumosa Therapeutics | 37.25M |
| Oneness Biotech | 112.57M |
| Polaris Group | 87.67M |
| Center Laboratories | 1.60B |